FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma

doi:10.4240/wjgs.v16.i6.1803

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1652)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-12) series, Tables (1-4) series.

Item

Count

PDF

HTML

1001

Figures (1-12)

173

Tables (1-4)

188

Sum=1404

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

159

Sum=188

Jun 27, 2024 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Gastrointest Surg. Jun 27, 2024; 16(6): 1803-1824
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1803

Full Size Figure Download Figure

Figure 9 Prognostic analysis and performance of predictive differentially expressed genes. A: Risk factor plot; B: Forest plot for univaiate Cox regression analysis of differentially expressed genes for copper death prognosis; C: 1-, 3- and 5-year calibration curve plots; D: Nomogram; E: 1-year decision curve analysis (DCA) plot for Least Absolute Shrinkage and Selection Operator (LASSO) regression prognosis model; F: 3-year DCA plot for LASSO regression prognosis model; G: 5-year DCA plot for LASSO regression prognosis model.

Citation: Xie XZ, Zuo L, Huang W, Fan QM, Weng YY, Yao WD, Jiang JL, Jin JQ. FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma. World J Gastrointest Surg 2024; 16(6): 1803-1824
URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1803.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1803